1. Home
  2. PSNL vs SITC Comparison

PSNL vs SITC Comparison

Compare PSNL & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • SITC
  • Stock Information
  • Founded
  • PSNL 2011
  • SITC 1965
  • Country
  • PSNL United States
  • SITC United States
  • Employees
  • PSNL N/A
  • SITC N/A
  • Industry
  • PSNL Medical Specialities
  • SITC Real Estate Investment Trusts
  • Sector
  • PSNL Health Care
  • SITC Real Estate
  • Exchange
  • PSNL Nasdaq
  • SITC Nasdaq
  • Market Cap
  • PSNL 518.8M
  • SITC 494.6M
  • IPO Year
  • PSNL 2019
  • SITC 1993
  • Fundamental
  • Price
  • PSNL $5.82
  • SITC $8.92
  • Analyst Decision
  • PSNL Strong Buy
  • SITC Buy
  • Analyst Count
  • PSNL 4
  • SITC 7
  • Target Price
  • PSNL $8.13
  • SITC $30.29
  • AVG Volume (30 Days)
  • PSNL 824.9K
  • SITC 1.1M
  • Earning Date
  • PSNL 11-05-2025
  • SITC 10-29-2025
  • Dividend Yield
  • PSNL N/A
  • SITC 53.52%
  • EPS Growth
  • PSNL N/A
  • SITC N/A
  • EPS
  • PSNL N/A
  • SITC 6.74
  • Revenue
  • PSNL $80,317,000.00
  • SITC $173,351,000.00
  • Revenue This Year
  • PSNL N/A
  • SITC N/A
  • Revenue Next Year
  • PSNL $29.83
  • SITC N/A
  • P/E Ratio
  • PSNL N/A
  • SITC $1.24
  • Revenue Growth
  • PSNL 0.36
  • SITC N/A
  • 52 Week Low
  • PSNL $2.83
  • SITC $8.60
  • 52 Week High
  • PSNL $7.79
  • SITC $18.15
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 60.46
  • SITC 32.51
  • Support Level
  • PSNL $5.48
  • SITC $8.60
  • Resistance Level
  • PSNL $6.26
  • SITC $9.09
  • Average True Range (ATR)
  • PSNL 0.33
  • SITC 0.25
  • MACD
  • PSNL 0.11
  • SITC -0.10
  • Stochastic Oscillator
  • PSNL 72.86
  • SITC 8.56

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.

Share on Social Networks: